GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Advanced Proteome Therapeutics Corp (TSXV:APC.H) » Definitions » Shiller PE Ratio

Advanced Proteome Therapeutics (TSXV:APC.H) Shiller PE Ratio : (As of May. 26, 2024)


View and export this data going back to 1989. Start your Free Trial

What is Advanced Proteome Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Advanced Proteome Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Advanced Proteome Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Proteome Therapeutics Shiller PE Ratio Chart

Advanced Proteome Therapeutics Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Advanced Proteome Therapeutics Quarterly Data
Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Advanced Proteome Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Advanced Proteome Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Proteome Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Advanced Proteome Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Advanced Proteome Therapeutics's Shiller PE Ratio falls into.



Advanced Proteome Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Advanced Proteome Therapeutics's E10 for the quarter that ended in Apr. 2023 is calculated as:

For example, Advanced Proteome Therapeutics's adjusted earnings per share data for the three months ended in Apr. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Apr. 2023 (Change)*Current CPI (Apr. 2023)
=-0.054/123.5712*123.5712
=-0.054

Current CPI (Apr. 2023) = 123.5712.

Advanced Proteome Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201307 0.000 97.261 0.000
201310 0.000 97.182 0.000
201401 -0.219 97.261 -0.278
201404 0.020 98.920 0.025
201407 0.107 99.315 0.133
201410 -0.013 99.473 -0.016
201501 -0.024 98.209 -0.030
201504 -0.035 99.710 -0.043
201507 0.000 100.579 0.000
201510 -0.015 100.500 -0.018
201601 -0.020 100.184 -0.025
201604 -0.016 101.370 -0.020
201607 -0.080 101.844 -0.097
201610 -0.020 102.002 -0.024
201701 -0.023 102.318 -0.028
201704 -0.020 103.029 -0.024
201707 -0.067 103.029 -0.080
201710 -0.013 103.424 -0.016
201801 -0.054 104.056 -0.064
201804 0.038 105.320 0.045
201807 -0.034 106.110 -0.040
201810 -0.026 105.952 -0.030
201901 0.013 105.557 0.015
201904 -0.003 107.453 -0.003
201907 -0.017 108.243 -0.019
201910 -0.001 107.927 -0.001
202001 -0.013 108.085 -0.015
202004 -0.008 107.216 -0.009
202007 -0.013 108.401 -0.015
202010 -0.013 108.638 -0.015
202101 0.001 109.192 0.001
202104 -0.062 110.851 -0.069
202107 0.013 112.431 0.014
202110 0.025 113.695 0.027
202201 0.025 114.801 0.027
202204 -0.013 118.357 -0.014
202207 -0.013 120.964 -0.013
202210 -0.014 121.517 -0.014
202301 -0.013 121.596 -0.013
202304 -0.054 123.571 -0.054

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Advanced Proteome Therapeutics  (TSXV:APC.H) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Advanced Proteome Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Advanced Proteome Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Proteome Therapeutics (TSXV:APC.H) Business Description

Traded in Other Exchanges
Address
8337 Eastlake Drive, Suite 104, Burnaby, BC, CAN, V5A 4W2
Advanced Proteome Therapeutics Corp is a biotechnology company. It develops and commercializes a platform to use protein modification technologies to create proprietary human protein pharmaceuticals with therapeutic properties. The company develops anti-cancer drugs for cancerous tumors that will destroy a cancer patient's tumor cells selectively, sparing healthy cells. All the operations of the organization are principally carried out in the United States.

Advanced Proteome Therapeutics (TSXV:APC.H) Headlines

No Headlines